Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:metformin
gptkb:vildagliptin |
| gptkbp:administeredBy |
oral
|
| gptkbp:approvedBy |
gptkb:European_Union
|
| gptkbp:ATCCode |
gptkb:A10BD08
|
| gptkbp:contraindication |
gptkb:type_1_diabetes_mellitus
gptkb:diabetic_ketoacidosis |
| gptkbp:drugClass |
antidiabetic combination
|
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Galvus Met
|
| gptkbp:marketedAs |
gptkb:Novartis
|
| gptkbp:mechanismOfAction |
DPP-4 inhibition and insulin sensitization
|
| gptkbp:pregnancyCategory |
not recommended
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:sideEffect |
gptkb:hypoglycemia
gastrointestinal disturbance lactic acidosis |
| gptkbp:usedFor |
gptkb:type_2_diabetes_mellitus
|
| gptkbp:bfsParent |
gptkb:Galvus
|
| gptkbp:bfsLayer |
5
|